Pleiades Device
My123Baby Medical Limited Dba Boost Fertility · Decision date Oct 30, 2026
What did the FDA decide?
FDA recorded a substantially equivalent (SESE) decision for the Pleiades Device, submitted by My123Baby Medical Limited Dba Boost Fertility of Munich, Germany, under 510(k) number K262066. The decision date is 2026-10-30, with the application received 06/22/2026. The listed medical specialty is Obstetrics/Gynecology and the product code is MQK. SESE in the 510(k) pathway denotes clearance as substantially equivalent; it is not a PMA approval.
The source data do not describe the device's components, materials, intended use, or any changed item relative to a predicate, and no summary statement is included. The applicant contact is listed as Daniel Wilson, with Proxima CRO as correspondent. Because the underlying device description and comparison are absent, the technical basis for the equivalence determination cannot be characterized here and remains unknown.
- Regulatory pathway
- 510(k) premarket notification
- Clinical specialty
- Obstetrics/Gynecology
- Decision date
- Oct 30, 2026
FDA source record · MedtechLedger’s explanation describes the recorded change.
Regulatory record facts
- Identifier
- K262066
- Regulatory pathway
- 510(k) premarket notification
- Product code
- MQK
- Decision code
- SESE
- Decision date
- Oct 30, 2026
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: Labware, Assisted Reproduction.
- Product code
- MQK
- FDA device class
- 2
FDA decision timeline
K262066 received
Application receipt date recorded by FDA.
K262066 · FDA decision
SESE
Related devices and submissions
Explore the linked device profile
Other records with product code MQK
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
CyperusK262276 | Contrario Medical, Inc. | 510(k) clearance | Oct 26, 2026 | FDA |
Fertilis microICSI DeviceK262090 | Fertilis Pty, Ltd. | 510(k) clearance | Oct 9, 2026 | FDA |
A shared product code identifies a classification relationship; it does not establish clinical equivalence.
Regulatory context
A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
My123Baby Medical Limited Dba Boost Fertility
- Headquarters
- Not reported
- Brand website
- Not reported
- FDA applicant address
- Munich
Sources and methodology
- Original FDA record: K262066
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 19, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records
